Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Will The Rising Tide Of Rx Omega-3s Float The Fish Oil Supplement Market?

This article was originally published in The Tan Sheet

Executive Summary

Omega-3 fish oils, once exclusive to the realm of dietary supplements, increasingly are swimming upstream into prescription drugs – a trend with both positive and negative implications for supplements.
Advertisement

Related Content

Doctors Often Recommend Omega-3 Supplements For High Cholesterol – Survey
Doctors Often Recommend Omega-3 Supplements For High Cholesterol – Survey
Pronutria Gains $12.5 Million Funding For Protein Product Trials
Nutrition Summit Touts Omega-3's Alpha Role In Reducing Health Care Costs
NBTY Agrees To $2.1M Settlement With FTC For False DHA Claims
Amarin Accelerates Timeline For NDA Filing Of AMR101
Solae, Cargill Swim Against Tide Of Fish Oil With Vegetarian Omega-3s
Fish Oil Firms Float Toxicology Work, Plot Media Blitz To Fight PCB Suit
Fish Oil Firms Float Toxicology Work, Plot Media Blitz To Fight PCB Suit
New GSK Global Switch/Strategy Position Supports Firm’s OTC Commitment

Topics

Advertisement
UsernamePublicRestriction

Register

PS104823

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel